❝
Happy Friday! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. Have a great weekend!
Hit the Gong 🎉
Source: @overheard_sales + @sales_bant_er
Daily Deals 💸
🌎 Americas
Ocular Therapeutix operates a biopharmaceutical company that focuses on developing and commercializing innovative therapies for eye diseases and conditions. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $325M, Post-IPO Equity
Round Investors: Perceptive Advisors, TCG Crossover, Opaleye Management, Great Point Partners
🚀Growth Focus: Accelerate the clinical development of AXPAXLI™ for the treatment of wet AMD; support its other clinical development programs.
Press: GlobeNewswire, BNN Breaking
HQ: Bedford, MA
Industry: Pharmaceutical Manufacturing
Employee Count: 259